Findlay Park Partners LLP Zoetis Inc. Transaction History

Findlay Park Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$151.44 - $200.09 $1.38 Million - $1.82 Million	-9,104 Reduced 2.56%	346,691 $68.4 Million
Q3 2023 Nov 07, 2023	SELL	$167.14 - $192.77 $560,420 - $646,357	-3,353 Reduced 0.93%	355,795 $61.9 Million
Q2 2023 Aug 04, 2023	SELL	$160.94 - $186.23 $2.58 Million - $2.99 Million	-16,050 Reduced 4.28%	359,148 $61.8 Million
Q1 2023 May 05, 2023	BUY	$145.48 - $175.02 $54.6 Million - $65.7 Million	375,198 New	375,198 $62.4 Million
Q3 2018 Nov 07, 2018	SELL	$83.5 - $93.23 $61.1 Million - $68.2 Million	-731,247 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$79.9 - $89.2 $7.99 Million - $8.92 Million	-100,000 Reduced 12.03%	731,247 $62.3 Million
Q1 2018 May 09, 2018	SELL	$71.51 - $84.69 $10.7 Million - $12.7 Million	-150,000 Reduced 15.29%	831,247 $69.4 Million
Q4 2017 Feb 08, 2018	SELL	$63.24 - $72.8 $22.5 Million - $25.8 Million	-355,000 Reduced 26.57%	981,247 $70.7 Million
Q3 2017 Nov 08, 2017	BUY	$59.73 - $65.4 $79.8 Million - $87.4 Million	1,336,247	1,336,247 $85.2 Million

1,948

408M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Findlay Park Partners LLP with notifications on news.